- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries
- Careers
- News & Insights
- About
- Languages
News 12 results
Cases & Deals
July 30, 2019
American Clinical Laboratory Association (ACLA) Wins Jurisdictional Decision in D.C. Circuit Court
Cases & Deals
August 16, 2018
King & Spalding Advises Cancer Prevention Pharmaceuticals on $185 Million Licensing Deal With Mallinckrodt
Cases & Deals
June 4, 2018
Linden Capital Partners acquires leading direct-to-patient DME supplier
Cases & Deals
January 9, 2018
King & Spalding Advises Incyte Corp. on Collaboration Agreement With Syros
Cases & Deals
October 4, 2017
King & Spalding Advises Apama Medical in Acquisition Deal by Boston Scientific Worth Up to $300 Million
Cases & Deals
August 9, 2017
King & Spalding Advises Dermira on Worldwide Licensing Agreement with Roche
Cases & Deals
July 20, 2016
King & Spalding Advises Jounce Therapeutics on Deal Worth Up to $2.5 Billion
Cases & Deals
March 24, 2016
King & Spalding Represents GSK on Strategic Collaboration with Miltenyi Biotec
Cases & Deals
September 17, 2015
King & Spalding Advises Nurix in $150 Million-Plus Drug Collaboration and Option Deal with Celgene
Cases & Deals
June 8, 2015
King & Spalding Team Advises Five Prime Therapeutics in $131 Million License Agreement with bluebird bio
Cases & Deals
Cases & Deals
December 5, 2014
King & Spalding Advises Arbor Pharmaceuticals in Minority-Stake Sale to KKR